Correction to: Immune‑related serious adverse events with immune checkpoint inhibitors: systematic review and network meta‑analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Immune‑related serious adverse events with immune checkpoint inhibitors: systematic review and network meta‑analysis ; volume:80 ; number:10 ; day:24 ; month:7 ; year:2024 ; pages:1597-1598 ; date:10.2024
European journal of clinical pharmacology ; 80, Heft 10 (24.7.2024), 1597-1598, 10.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Oliveira, Clara
Mainoli, Beatrice
Duarte, Gonçalo S.
Machado, Tiago
Tinoco, Rita G.
Esperança‑Martins, Miguel
Ferreira, Joaquim J.
Costa, João
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-024-03732-3
- URN
-
urn:nbn:de:101:1-2411262104248.705372553572
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oliveira, Clara
- Mainoli, Beatrice
- Duarte, Gonçalo S.
- Machado, Tiago
- Tinoco, Rita G.
- Esperança‑Martins, Miguel
- Ferreira, Joaquim J.
- Costa, João
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Managing immune-related adverse events in oncology
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Managing immune-related adverse events in oncology
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Managing immune-related adverse events in oncology
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events